Trials / Completed
CompletedNCT01925313
A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study objectives * To compare the safety and pharmacokinetic properties of CJ-30044 and bepotastine besylate after a single oral administration in healthy male volunteers. * To evaluate the food-effect on pharmacokinetics of CJ-30044 after a single oral administration in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CJ-30044 | 20.51mg a day,PO,QD |
| DRUG | TALION TAB. 10mg | 10mg a day,PO,BID |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-02-01
- Completion
- 2013-05-01
- First posted
- 2013-08-19
- Last updated
- 2013-08-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01925313. Inclusion in this directory is not an endorsement.